Industry associations representing the chemical sectors in the United States and Canada are urging their governments to return to the negotiating table after talks failed to produce a deal.
The new Mumbai, India, facility will offer technical testing and application support to diaper and hygiene product customers worldwide.
LG Energy Solution to produce battery cells for EVs and energy storage systems at its Lansing, Michigan facility, supporting U.S. domestic content requirements.
European Energy and Mitsui & Co have entered into a multi-year purchase agreement with OMV for renewable e-methanol from the Kassø e-methanol plant in Aabenraa, Denmark.
Piramal Pharma strengthens its biologics CDMO business, converting Yapan Bio from associate company to subsidiary and expanding vaccine and biologics manufacturing capabilities.
The first personalized mRNA cancer therapy to beat the standard of care is now headed for regulators.
Production resumes at the Hartlepool facility following LB Group's acquisition, with full capacity targeted by early 2027.
The two companies renew their global cooperation agreement, extending two decades of collaboration on lubricants and clean mobility.
SOCMA survey finds 93% of chemical manufacturers say faster TSCA Section 5 reviews would boost US reshoring.
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
Ecolyte, a women-led start-up from Azerbaijan, has developed a non-flammable electrolyte for lithium-ion batteries used in electric vehicles.
H.B. Fuller announced that shareholders of Advanced Medical Solutions (AMS) approved H.B. Fuller’s proposed acquisition of AMS.
H.B. Fuller confirmed receipt of an unsolicited proposal from Ancora Holdings to acquire its Building Adhesives Solutions business for between $1.1 billion and $1.2 billion in cash.
Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.
The partnership gives Asahi Kasei a foothold for expanding its electrolyte technology to the Chinese market.
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
Sasol commissioned Envision Energy for a green hydrogen design study at Sasolburg, evaluating renewables, storage, and electrolysers to produce eMethanol and sustainable aviation fuel.
In a stagnant European market, chemical distribution is evolving from an efficiency lever into a strategic growth partner.
Univar Solutions has acquired Interpur Chemicals, a leading distributor of polyurethanes and powder coatings in Europe.
New 12.5% US tariffs push Scienceindustries to urge a swift Swiss-US bilateral economic agreement to protect chemical, pharma, and life sciences trade.
The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.
The project represents a major milestone in the industrial deployment of Catalyxx’s technology and has been recognized as a Project of National Interest (PIN) by the Portuguese Government.
The next phase of expansion for the Greenfield project in Sisslerfeld (Eiken, Switzerland) will be carried out as part of a strategic partnership. The total investment amounts to more than 500 million CHF.
Fully integrated production in Mobile, Alabama (USA) strengthens supply reliability in the Americas. Completion of backward integration across hubs in Mobile, Antwerp, and Singapore enhances global competitiveness.
Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).
An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.
Despite positive elements, the ETS revision proposal risks cutting industry, not emissions.
DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.
As Managing Director, Lisa will provide strategic leadership for BASF in the UK, supporting the company’s licence to operate and ensuring the business continues to contribute to BASF’s long-term success.
Ovomas, a start-up from Ecuador, creates high-value pharmaceutical products from eggshell waste, including high-purity calcium citrate, nutraceutical capsules, and vitamin-enriched gummies.
Air Liquide is investing over $160 million to build a new Arizona facility supplying ultra-high-purity gases, including low-carbon hydrogen, to a leading chipmaker's fab expansion, starting operations in 2028.
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Shell has agreed to sell its Sprng Energy renewables business in India to Aditya Birla Renewables for $1.8 billion, as part of its strategy to streamline and improve returns in its power portfolio.
